Dexmedetomidine Preparation and Infusion Rate Calculation
Dilute dexmedetomidine to 4 mcg/mL in 0.9% sodium chloride or 5% dextrose, then calculate the infusion rate using the formula: (patient weight in kg × desired dose in mcg/kg/hr) ÷ 4 mcg/mL = mL/hr.
Preparation and Dilution
Dexmedetomidine requires dilution before administration. The standard preparation involves:
- Concentration: Dilute to 4 mcg/mL (this is the most commonly used concentration) 1
- Diluent: Use 0.9% sodium chloride or 5% dextrose in water
- Example: Add 2 mL of dexmedetomidine 100 mcg/mL (200 mcg total) to 48 mL of diluent to create 50 mL at 4 mcg/mL
- Stability: Once diluted to 4 mcg/mL in 0.9% sodium chloride, the solution remains stable for 14 days under refrigeration and 48 hours at room temperature in both PVC and non-PVC bags 2
Dosing Regimen
ICU Sedation
Loading Dose (optional, use with caution):
- 1 mcg/kg IV over 10 minutes 1
- Critical caveat: Avoid loading doses in hemodynamically unstable patients due to risk of transient hypertension followed by hypotension and bradycardia 1
Maintenance Infusion:
- Standard range: 0.2 to 0.7 mcg/kg/hr 1
- Maximum approved dose: 0.7 mcg/kg/hr for ICU sedation (FDA-approved for <24 hours)
- Extended use: Can be safely increased to 1.5 mcg/kg/hr and continued beyond 24 hours (up to 28 days) based on clinical studies, though this exceeds FDA labeling 1
Procedural Sedation
- Loading: 1 mcg/kg over 10 minutes
- Maintenance: 0.2 mcg/kg/hr, can increase to 1.0 mcg/kg/hr for procedures 3, 4
Infusion Rate Calculation
Step-by-step calculation for 4 mcg/mL concentration:
- Determine desired dose (e.g., 0.5 mcg/kg/hr for moderate sedation)
- Calculate total mcg/hr needed: Patient weight (kg) × desired dose (mcg/kg/hr)
- Convert to mL/hr: Total mcg/hr ÷ 4 mcg/mL = mL/hr
Example for 70 kg patient at 0.5 mcg/kg/hr:
- 70 kg × 0.5 mcg/kg/hr = 35 mcg/hr
- 35 mcg/hr ÷ 4 mcg/mL = 8.75 mL/hr
Quick reference formula:
mL/hr = (Weight in kg × Dose in mcg/kg/hr) ÷ 4Titration Strategy
Start at the lower end of the dosing range (0.2 mcg/kg/hr) and titrate upward based on sedation goals 1:
- Assess sedation level every 15-30 minutes initially
- Increase by 0.1-0.2 mcg/kg/hr increments as needed
- Peak effect occurs within 1 hour of starting infusion 1
- Onset of sedation within 15 minutes 1
Critical Safety Considerations
Hemodynamic monitoring is mandatory due to biphasic cardiovascular effects 3:
- During loading dose: Expect transient hypertension (peripheral α-2 stimulation) within 5-10 minutes
- After loading/during maintenance: Blood pressure typically decreases 10-20% from baseline
- Bradycardia: Common adverse effect; monitor heart rate continuously 1
- Hypotension: Most common side effect, particularly with loading doses 1
Respiratory considerations:
- Minimal respiratory depression compared to benzodiazepines 1
- Can cause loss of oropharyngeal muscle tone leading to airway obstruction in non-intubated patients 1
- Continuous respiratory monitoring required for non-intubated patients 1
Special Populations
Hepatic dysfunction:
- Reduce maintenance dose due to impaired clearance and prolonged elimination half-life (normally ~3 hours) 1
- Titrate more conservatively
Hemodynamically unstable patients:
- Omit loading dose entirely 1
- Start maintenance infusion at lowest effective dose (0.2 mcg/kg/hr)
Common Pitfalls to Avoid
- Do not administer loading dose rapidly: Always infuse over 10 minutes minimum to minimize hypertensive response
- Do not use in patients with baseline bradycardia or heart block without careful consideration
- Do not assume dexmedetomidine provides complete analgesia: It has opioid-sparing effects but may require supplemental analgesia 1, 5
- Do not exceed 1.5 mcg/kg/hr without compelling clinical indication and close monitoring